Sponsor Pipeline

Shenyang Sunshine Pharmaceutical Co., LTD. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
21
Active Trials
12
Recruiting
1
Phase 3
6
Disease Areas
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-08-11 NCT07757230 A Phase II Study of SSGJ-612 Plus a HER2-Targeted ADC in HR-Positive, HER2-Low or… Phase 2 Not Yet Recruiting
Active Trials by Phase
Phase 3
1
Phase 2
7
Phase 1/2
2
Phase 1
11
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06980272 SSGJ-707 in Advanced Non-Small Cell Lung Cancer Advanced Non-Small Cell Lung Cancer Recruiting
Phase 2
NCT07022002 SSGJ-705 Monotherapy and Combination Therapy in Advanced HER2-Expressing Solid Tumors Locally Advanced, Recurrent or Metastatic Malignancies Recruiting
NCT07171606 A Phase II Study of SSGJ-706 Monotherapy and Combination Therapy in Advanced Non-Small… First-line Advanced NSCLC Patients Recruiting
NCT07646626 SSGJ-705 Plus SSGJ-612 ± Chemotherapy in Advanced HER2-Expressing Solid Tumors Locally Advanced (Unresectable) or Metastatic Solid Tumors Recruiting
NCT06854276 Study of SSS06 for Chemotherapy-Induced Anemia in Non-Myeloid Malignancies Chemotherapy-induced Anemia Not Yet Recruiting
NCT07007936 Phase IIa Trial of Oral SSS17 for Post-Arthroplasty Anemia Postoperative Anemia Not Yet Recruiting
NCT07233850 A Phase II Clinical Study Evaluating SSGJ-706 in Combination Therapy for Advanced… Gastric/Gastroesophageal Junction Adenocarcinoma Not Yet Recruiting
NCT07757230 A Phase II Study of SSGJ-612 Plus a HER2-Targeted ADC in HR-Positive, HER2-Low or… Metastatic Breast Cancer Not Yet Recruiting
Phase 1/2
NCT07008703 Phase I Study of sss40 Injection for Moderate-to-Severe Bone Metastatic Cancer Pain Cancer Pain Recruiting
NCT07445308 The Study is to Evaluate the Safety and Tolerability of SPGL008 Alone or in Combination… NMIBC Not Yet Recruiting
Phase 1
NCT06944444 A Phase I Clinical Study of SSS59 Monotherapy in Patients With Advanced Malignant Tumors Malignant Tumors Recruiting
NCT06629376 Safety, Tolerability, and Pharmacokinetic Characteristics of SSS11 in Patients With Gout… Gout Recruiting
NCT06993870 Phase I Study of HBT-708 for Patients With Advanced Solid Tumors Advanced Solid Tumors Recruiting
NCT07032298 A Phase I Study of SSGJ-612 in Patients With Advanced Solid Tumors Advanced Malignant Tumors Recruiting
NCT07016490 A Phase 1 Study of SSGJ-709 in Patients With Advanced Malignant Tumors Advanced Malignant Tumors Recruiting
NCT07038005 A Phase I Study of SPGL008 in Subjects With Advanced Malignant Tumors Advanced Malignant Tumors Recruiting
NCT07058779 Safety, Tolerability, PK and PD of SSS55 in Healthy Subjects Safety Issues Recruiting
NCT07025915 A Phase 1 Mass Balance Study of [¹⁴C]SSS17 in Healthy Chinese Males Healthy Subjects (HS) Not Yet Recruiting
NCT07057726 A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of SSS39 Injection in… Safety and Tolerability in Healthy Volunteers Enrolling by Invitation
NCT07487545 Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Immunogenicity of SSS67 in… Healthy Not Yet Recruiting
NCT07606976 A Study of SSS68 Following a Single Subcutaneous Administration in Healthy Adult… Healthy Not Yet Recruiting
Disease Areas
Get alerts when Shenyang Sunshine Pharmaceutical Co., LTD.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free